These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17098845)

  • 21. Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study.
    Pintor LP; Valldeoriola F; Fernández-Egea E; Sánchez R; Rami L; Tolosa E; Muñiz A; Martí MJ; Bernardo M
    J ECT; 2012 Jun; 28(2):87-91. PubMed ID: 22531200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic and non-dopaminergic gait components assessed by instrumented timed up and go test in Parkinson's disease.
    Dibilio V; Nicoletti A; Mostile G; Toscano S; Luca A; Raciti L; Sciacca G; Vasta R; Cicero CE; Contrafatto D; Zappia M
    J Neural Transm (Vienna); 2017 Dec; 124(12):1539-1546. PubMed ID: 29018993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: three years follow-up.
    Gan J; Xie-Brustolin J; Mertens P; Polo G; Klinger H; Mollion H; Benatru I; Henry E; Broussolle E; Thobois S
    J Neurol; 2007 Jan; 254(1):99-106. PubMed ID: 17508144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease.
    Evans AH; Lawrence AD; Lees AJ
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):267-72. PubMed ID: 18977820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
    Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication.
    Murakami H; Momma Y; Nohara T; Mori Y; Futamura A; Sugita T; Ishigaki S; Katoh H; Kezuka M; Ono K; Miller MW; Kawamura M
    J Parkinsons Dis; 2016; 6(1):209-17. PubMed ID: 26889633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin type B for gait freezing in Parkinson's disease.
    Fernandez HH; Lannon MC; Trieschmann ME; Friedman JH
    Med Sci Monit; 2004 Jul; 10(7):CR282-4. PubMed ID: 15232500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.
    Ondo WG; Fayle R; Atassi F; Jankovic J
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1636-9. PubMed ID: 16291885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson's disease: A single-arm, open-label, prospective, multicenter study.
    Iijima M; Orimo S; Terashi H; Suzuki M; Hayashi A; Shimura H; Mitoma H; Kitagawa K; Okuma Y
    Expert Opin Pharmacother; 2019 Aug; 20(11):1405-1411. PubMed ID: 31039621
    [No Abstract]   [Full Text] [Related]  

  • 32. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease.
    Moreau C; Defebvre L; Destée A; Bleuse S; Clement F; Blatt JL; Krystkowiak P; Devos D
    Neurology; 2008 Jul; 71(2):80-4. PubMed ID: 18420482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson's disease.
    Matsuura K; Kajikawa H; Tabei KI; Satoh M; Kida H; Nakamura N; Tomimoto H
    Neurosci Lett; 2018 Jan; 662():158-161. PubMed ID: 29031781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylphenidate : a treatment for Parkinson's disease?
    Devos D; Moreau C; Delval A; Dujardin K; Defebvre L; Bordet R
    CNS Drugs; 2013 Jan; 27(1):1-14. PubMed ID: 23160937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease.
    Arena JE; Cerquetti D; Rossi M; Chaves H; Rollan C; Dossi DE; Merello M
    Parkinsonism Relat Disord; 2016 Mar; 24():126-8. PubMed ID: 26823237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease.
    Ferraye MU; Debû B; Fraix V; Goetz L; Ardouin C; Yelnik J; Henry-Lagrange C; Seigneuret E; Piallat B; Krack P; Le Bas JF; Benabid AL; Chabardès S; Pollak P
    Brain; 2010 Jan; 133(Pt 1):205-14. PubMed ID: 19773356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcranial direct current stimulation for treatment of freezing of gait: a cross-over study.
    Valentino F; Cosentino G; Brighina F; Pozzi NG; Sandrini G; Fierro B; Savettieri G; D'Amelio M; Pacchetti C
    Mov Disord; 2014 Jul; 29(8):1064-9. PubMed ID: 24789677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease.
    Mostile G; Nicoletti A; Dibilio V; Luca A; Raciti L; Sciacca G; Cicero CE; Vasta R; Donzuso G; Contrafatto D; Zappia M
    Clin Neuropharmacol; 2017; 40(1):6-10. PubMed ID: 27879548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-DOPA treatment in Parkinson's disease.
    Crenna P; Carpinella I; Lopiano L; Marzegan A; Rabuffetti M; Rizzone M; Lanotte M; Ferrarin M
    Brain; 2008 Dec; 131(Pt 12):3410-20. PubMed ID: 18952669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.